Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Clermont-Ferrand
The study is prospective, parallel, double-blind, randomized, placebo-controlled analysis with intent to treat. There are 2 groups:
* A group N: néfopam
* A group P: placebo And all the patient receive, before randomization, 100 mg of ketoprofen (Profenid ®) on 20 minutes.
The number of subjects is 52.
Age
18–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age between 18 to 50 years old.
Admitted to the emergency room for typical ureteral calculi with severe pain (VAS \> or = 60), and microscopic hematuria in the strip without signs of urinary complications.
Preliminary Agreement patient.
You may not be if
Patient disagree.
Pregnant women (sought by the questioning).
Fever \> 38 ° C.
Leucocyturie or nitriturie (dipstick).
Contraindication to ketoprofen.
Contraindication to néfopam.
Contraindication to morphine.
Contraindication linked to drug interactions as mentioned in the Summary of Product Characteristics of the Authorization for placing on the market of Acupan ®.
Treatment opioid analgesics, nonsteroidal anti-inflammatory or inflammatory or paracetamol in the previous 12 hours.
Secondary exclusion to a urinary tract infection or systemic.